All Stories

  1. Efficacy and Tolerability of Generic Pirfenidone After Switch from Esbriet® in Idiopathic Pulmonary Fibrosis: A Real-World Observational Study
  2. Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection
  3. Alpha-1 Antitrypsin Deficiency Beyond COPD and Emphysema: A Narrative Review
  4. High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial
  5. Physiopathology of Exacerbation of Chronic Obstructive Pulmonary Disease
  6. Multiperspective ultrasonography in COPD exacerbations: insights into inspiratory muscle recruitment and clinical outcomes. Author’s reply
  7. The forgotten airway: central airway pathology in the ICU
  8. Idiopathic Pulmonary Fibrosis: Analysis of Predisposing Variants in Patients with Familial Forms
  9. Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets
  10. Digital twins of acute hypoxemic respiratory failure and sepsis patients suggest potential benefits of bi-level high flow nasal cannula therapy
  11. Stent and Resection Anastomosis in Patients with Complex Tracheal Stenosis: The Stars Retrospective Multicenter Trial
  12. Ultrasound-based evaluation of inspiratory muscle effort in patients with type 2 respiratory failure secondary to exacerbation of chronic obstructive pulmonary disease
  13. Optimization of intranasal bleomycin dose for effective pulmonary fibrosis induction in mice with minimal animal distress
  14. Evaluating the effect of heart and respiratory rate measurement errors on the ability to predict the outcome of high flow nasal cannula therapy: a multi-centre study
  15. Predicting and Treating Pulmonary Fibrosis with Proteomic Biomarker Investigations
  16. Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial
  17. Assessing inspiratory drive and effort in critically ill patients at the bedside
  18. Early prediction of non-invasive ventilation outcome using the TabPFN machine learning model: a multi-centre validation study
  19. Refining the predictive value of nasal pressure swing in acute hypoxemic respiratory failure management. Author's reply
  20. The use of the MoCA in cognitive impairment for older patients with Chronic Obstructive Pulmonary disease: A preliminary study
  21. Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents
  22. Digital twins suggest a mechanistic basis for differing responses to increased flow rates during high-flow nasal cannula therapy
  23. Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure
  24. Role of COVID‐19 in the Progression of Scleroderma Interstitial Lung Disease and New Onset Pulmonary Hypertension: A Challenging Case Report
  25. The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options—A Review
  26. Machine learning models compared with current clinical indices to predict the outcome of high flow nasal cannula therapy in acute hypoxemic respiratory failure
  27. Respiratory Muscle Dysfunction and Associated Risk Factors Following COVID-19-Related Hospitalisation
  28. Airway pressures generated by high flow nasal cannula in patients with acute hypoxemic respiratory failure: a computational study
  29. Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences
  30. Rehabilitation and physiotherapists in the critical care medicine
  31. Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study
  32. Quantitative CT-analysis of over aerated lung tissue and correlation with fibrosis extent in patients with idiopathic pulmonary fibrosis
  33. Bronchiectasis as long-term complication of acute fire smoke inhalation?
  34. Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing
  35. Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study protocol for a multicentre European observational study
  36. Expression of HOXB7 in the Lung of Patients with Idiopathic Pulmonary Fibrosis: A Proof-of-Concept Study
  37. Stress–strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation
  38. Digital Twins of Acute Hypoxemic Respiratory Failure Patients Suggest a Mechanistic Basis for Success and Failure of Noninvasive Ventilation
  39. Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
  40. Integrated endoscopic treatment of primitive unresectable tracheal tumor: the INTACT retrospective cohort study
  41. When sarcoidosis hits down: a case of prostatic sarcoidosis
  42. Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a multicentre European observational study
  43. Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?
  44. Impact of Frailty on Symptom Burden in Chronic Obstructive Pulmonary Disease
  45. Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis
  46. Efficacy of Respiratory Muscle Training in the Immediate Postoperative Period of Cardiac Surgery: A Systematic Review and Meta-Analysis
  47. Home noninvasive ventilation in severe COPD: in whom does it work and how?
  48. Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate orders
  49. COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
  50. Disease burden of people with uncontrolled severe asthma with and without biomarkers of inflammation
  51. Inspiratory Effort and Respiratory Mechanics in Patients with Acute Exacerbation of Idiopathic Pulmonary fibrosis: A Preliminary Matched Control Study
  52. Stress-strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation
  53. Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
  54. Physiological effects of lung-protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study
  55. The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
  56. Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
  57. Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis
  58. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
  59. Frailty Prevalence and Association with Clinical Outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease
  60. Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma
  61. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes
  62. Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
  63. Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia
  64. One‐year clinical experience on the use of Nintedanib in systemic sclerosis
  65. Case report: Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula
  66. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
  67. Accuracy of Nasal Pressure Swing to Predict Failure of High-Flow Nasal Oxygen in Patients with Acute Hypoxemic Respiratory Failure
  68. Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
  69. COPD: Providing the right treatment for the right patient at the right time
  70. Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
  71. Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft
  72. Biological effects of COVID-19 on lung cancer: Can we drive our decisions
  73. Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial
  74. Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study
  75. The burden of disease in people with mild asthma
  76. Treatable traits in the NOVELTY study
  77. The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
  78. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
  79. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
  80. Persistent asthma hospitalisations and deaths require a national asthma prevention plan
  81. Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study
  82. Risk Factors for Pulmonary Air Leak and Clinical Prognosis in Patients With COVID-19 Related Acute Respiratory Failure: A Retrospective Matched Control Study
  83. Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure
  84. Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
  85. Rehabilitation of Difficult-to-Wean, Tracheostomized Patients Admitted to Specialized Unit: Retrospective Analyses over 10-Years
  86. Stenting versus balloon dilatation in patients with tracheal benign stenosis: The STROBE trial
  87. Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults
  88. Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study
  89. Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  90. Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome
  91. First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
  92. Extensive Tracheal Injuries: A Reasoned Multistep Approach to Guarantee Mechanical Ventilatory Support Developed During the COVID‐19 Pandemic
  93. Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study
  94. In memoriam Claudio F. Donner
  95. Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome
  96. Urgent need of novel biomarkers of acute dyspnea
  97. Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
  98. Acute severe asthma: management and treatment
  99. Combined approach to define the clinical impact and decision making in asthmatics
  100. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
  101. Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  102. ERS/EAACI statement on adherence to international adult asthma guidelines
  103. Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study
  104. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
  105. Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
  106. Changes in Clinical Characteristics and Outcomes of Patients Admitted to Inpatient Cardiac Rehabilitation
  107. Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
  108. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
  109. Rehabilitative practice in Europe: Roles and competencies of physiotherapists. Are we learning something new from COVID-19 pandemic?
  110. Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
  111. Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung
  112. Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
  113. Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
  114. Never Give Up: Lesson learned from a severe COVID-19 patient
  115. Defining Modern Pulmonary Rehabilitation. An Official American Thoracic Society Workshop Report
  116. COVID-Guide: una app per il triage e l’autovalutazione della covid-19
  117. Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.
  118. Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario
  119. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
  120. Looking Ahead in Pulmonary Rehabilitation
  121. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
  122. Reply to Spinelli et al. and to Jha: Continued Vigorous Inspiratory Effort as a Predictor of Noninvasive Ventilation Failure
  123. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial
  124. Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study
  125. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
  126. Unusual effectiveness of systemic steroids in Whipple disease
  127. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
  128. Echoendoscopic appearance of mediastinal metastasis from papillary renal carcinoma
  129. Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE)
  130. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)
  131. Reply to Tuffet et al. and to Michard and Shelley
  132. Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies
  133. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study
  134. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia
  135. Tocilizumab in patients with severe COVID-19: a retrospective cohort study
  136. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
  137. Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease
  138. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
  139. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a st...
  140. Italian suggestions for pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: results of a Delphi process
  141. COVID-19 and pulmonary rehabilitation: preparing for phase three
  142. Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis
  143. An Italian sacrifice to the COVID-19 epidemic
  144. High-Flow Oxygen Therapy During Exercise Training in Patients With Chronic Obstructive Pulmonary Disease and Chronic Hypoxemia: A Multicenter Randomized Controlled Trial
  145. Handling and Processing of Blood Specimens from Patients with COVID‐19 for Safe Studies on Cell Phenotype and Cytokine Storm
  146. Obstructive sleep apnea and blood pressure in young hypertensives: does it matter?
  147. Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball”
  148. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
  149. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper
  150. Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients
  151. Vessel Diseases
  152. A case of dyspnea: respiratory failure due to pulmonary arteriovenous malformation
  153. Prognostication by concomitant organ failure in mechanically ventilated patients in ICU: Important issue to face with
  154. Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment
  155. Respiratory Mechanics and Diaphragmatic Dysfunction in COPD Patients Who Failed Non-Invasive Mechanical Ventilation
  156. Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting
  157. Gender differences in chronic obstructive pulmonary disease: Can be the DRG-based diagnosis the best way for a right analysis?
  158. Atypical diagnosis for typical lung carcinoid
  159. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD
  160. Serial ultrasound assessment of diaphragmatic function and clinical outcome in patients with amyotrophic lateral sclerosis
  161. Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
  162. Janus-faced amiodarone-induced pneumopathy
  163. Clinical differences in sarcoidosis patients with and without lymphoma
  164. Do Not Forget to Assess the Muscle Integrity in Patients With COPD
  165. Introduction of the harmonised respiratory physiotherapy curriculum
  166. A guide for respiratory physiotherapy postgraduate education: presentation of the harmonised curriculum
  167. Manual Massage Therapy for Patients with COPD: A Scoping Review
  168. Exercise and Sports Pulmonology
  169. Cardiac disease
  170. Pulmonary Rehabilitation
  171. Assessment of Symptoms in Patients with COPD: Strengths and Limitations of Clinical Scores
  172. LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
  173. Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure
  174. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure
  175. An uncommon cause of hemoptysis: aortobronchial fistula
  176. Tai Chi Recreational Exercise Is Not Rehabilitation
  177. Evaluation of health-related quality of life in pulmonary diseases
  178. The encaged lung: rapidly progressive idiopathic pleurisy
  179. Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma
  180. Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
  181. Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation
  182. Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
  183. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
  184. Update in rehabilitation of respiratory patients
  185. Looking for a chronic care model in COPD patients
  186. Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
  187. Incidence, Etiology, and Clinicopathologic Features of Endobronchial Benign Lesions
  188. Conventional Programs: Settings, Cost, Staffing, and Maintenance
  189. Conclusions: Perspectives in Pulmonary Rehabilitation
  190. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study
  191. Chronic Respiratory Abnormalities in the Multi-Morbid Frail Elderly
  192. Update on physiotherapy applicable to patients in intensive care. Practical aspects and perspectives
  193. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects
  194. The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients
  195. Integrating the care of the complex COPD patient
  196. GOLD 2017 recommendations for COPD patients: toward a more personalized approach
  197. COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply
  198. An uncommon cause of pneumonia: The golden diagnosis
  199. Prevalence and outcomes of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of COPD: A pilot study
  200. What is the origin of dyspnoea in smokers without airway disease?
  201. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
  202. Management and Therapy for Pulmonary Hypertension: 2016 Update
  203. Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis
  204. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease
  205. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers
  206. Activity and analysis of costs in a dedicated weaning centre
  207. Learning impact of education during Pulmonary Rehabilitation program. An observational short-term cohort study
  208. Organization of a Weaning Unit
  209. La ventilazione non invasiva in Medicina Interna
  210. Advanced COPD patients under Home Mechanical Ventilation and/or Long Term Oxygen Therapy: Italian Healthcare Costs
  211. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation
  212. Response to pulmonary rehabilitation: toward personalised programmes?
  213. Chronic critical illness: the price of survival
  214. 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – Part 3
  215. 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2
  216. 8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1
  217. Comorbidities in elderly smokers with COPD or CHF
  218. Impaired function in the complex patient with COPD: a matter to be considered
  219. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
  220. Clinical highlights: messages from Munich
  221. Development of a syllabus for postgraduate respiratory physiotherapy education: the Respiratory Physiotherapy HERMES project
  222. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
  223. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
  224. A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes
  225. Symptomatic, frail, elderly patients: the urgent need for comprehensive assessment and management: Figure 1–
  226. A conceptual framework for reporting experience of physical activity in COPD
  227. Pulmonary rehabilitation in Italy: professional barriers to overcome
  228. An official European Respiratory Society statement on physical activity in COPD
  229. A core syllabus for post-graduate training in respiratory physiotherapy
  230. In COPD patients on prolonged mechanical ventilation heart rate variability during the T-piece trial is better after pressure support plus PEEP: A pilot physiological study
  231. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial
  232. Impaired arm activity in COPD: a questionable goal for rehabilitation
  233. Clinical highlights from the 2013 ERS Congress in Barcelona
  234. Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease
  235. Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
  236. Multimorbidity in Elderly Patients with Chronic Obstructive Pulmonary Disease: Stop Smoking! Go Exercise?
  237. Differences in content and organisational aspects of pulmonary rehabilitation programmes
  238. Fat-Free Mass Depletion Is Associated With Poor Exercise Capacity Irrespective of Dynamic Hyperinflation in COPD Patients
  239. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
  240. Chronic Obstructive Pulmonary Disease (COPD) and Metabolic Disorders in Elderly Smokers
  241. Towards health benefits in chronic respiratory diseases: pulmonary rehabilitation
  242. Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease
  243. Noninvasive mechanical ventilation with high pressure strategy remains a “double edged sword”?
  244. Systemic Inflammatory Pattern of Patients With Community-Acquired Pneumonia With and Without COPD
  245. Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity
  246. Chronic Obstructive Pulmonary Disease Is Just One Component of the Complex Multimorbidities in Patients with COPD
  247. Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease
  248. Predicting Walking-Induced Oxygen Desaturations in COPD Patients: A Statistical Model
  249. Feasibility and Effectiveness of an Educational Program in Italian COPD Patients Undergoing Rehabilitation
  250. Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals
  251. Effect of Rehabilitative Exercise Training on Peripheral Muscle Remodelling in Patients with COPD: Targeting Beyond the Lungs
  252. Pulmonary Rehabilitation Improves Cardiovascular Response to Exercise in COPD
  253. Respiratory Muscle Training in Patients Recovering Recent Open Cardiothoracic Surgery: A Randomized-Controlled Trial
  254. Selected clinical highlights from the 2012 ERS congress in Vienna: Table 1–
  255. Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial
  256. Pulmonary rehabilitation following radical chemo-radiation in locally advanced non surgical NSCLC: Preliminary evidences
  257. Clinical highlights from the 2011 ERS Congress in Amsterdam
  258. Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients
  259. Rehabilitation, weaning and physical therapy strategies in chronic critically ill patients
  260. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients
  261. Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation
  262. Co-morbidities in chronic respiratory patients: limitations or opportunities for caring?
  263. COPD and the metabolic syndrome: an intriguing association
  264. Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients
  265. Energy Expenditure at Rest and during Walking in Patients with Chronic Respiratory Failure: A Prospective Two-Phase Case-Control Study
  266. Rehabilitation in COPD patients: evergreen in pneumology and beyond
  267. Safety and Efficacy of Short-Term Intrapulmonary Percussive Ventilation in Patients With Bronchiectasis
  268. Selected clinical highlights from the 2010 ERS Congress in Barcelona
  269. Complessità del paziente con insufficienza respiratoria cronica associata a BPCO
  270. Functional Recovery Following Physical Training in Tracheotomized and Chronically Ventilated Patients
  271. Non-invasive ventilation in elderly patients with acute hypercapnic respiratory failure: a randomised controlled trial
  272. Non-invasive Ventilation and Weaning: Principles and Practice
  273. Early Rehabilitation
  274. Efficacy of standard rehabilitation in COPD outpatients with comorbidities
  275. Measures of dyspnea in pulmonary rehabilitation
  276. Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Soci...
  277. Erratum to: Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study
  278. Effects of early inpatient rehabilitation after acute exacerbation of COPD
  279. Patients’ characterization, hospital course and clinical outcomes in five Italian respiratory intensive care units
  280. "ERS/ESTS CLINICAL GUIDELINES ON FITNESS FOR RADICAL THERAPY IN LUNG CANCER PATIENTS (SURGERY AND CHEMO-RADIOTHERAPY)". A. BRUNELLI, A. CHARLOUX, C.T. BOLLIGER, G. ROCCO, J-P. SCULIER, G. VARELA, M. LICKER, M.K. FERGUSON, C. FAIVRE-FINN, R.M. HUBER, E....
  281. Last 3 months of life in home-ventilated patients: the family perception
  282. Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study
  283. Effects of Unsupported Upper Extremity Exercise Training in Patients With COPD
  284. Long-term Weight Loss and Maintenance in Morbidly Obese Individuals with Obstructive Sleep Apnea
  285. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer
  286. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
  287. Short-term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review
  288. Use of functional independence measure in rehabilitation of inpatients with respiratory failure
  289. Exercise Capacity as a Pulmonary Rehabilitation Outcome
  290. Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial
  291. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects
  292. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
  293. Predictors of 6-Month Mortality in Elderly Patients with Mild Chronic Obstructive Pulmonary Disease Discharged from a Medical Ward After Acute Nonacidotic Exacerbation
  294. Home Non-Invasive Mechanical Ventilation and Long-Term Oxygen Therapy in Stable Hypercapnic Chronic Obstructive Pulmonary Disease Patients: Comparison of Costs
  295. Indications and Physiological Basis of Rehabilitation in the ICU
  296. Nutrition in ICU
  297. Nonpharmacological treatment and relief of symptoms in COPD
  298. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study
  299. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer
  300. Effects of a Walking Aid in COPD Patients Receiving Oxygen Therapy
  301. Respiratory muscles training in COPD patients
  302. Intrapulmonary percussive ventilation in tracheostomized patients: a randomized controlled trial
  303. Maximal inspiratory and expiratory pressure measurement in tracheotomised patients
  304. Repeated Pulmonary Rehabilitation in Severe and Disabled COPD Patients
  305. Inspiratory Muscle Training: A Way to Breathe More Easily
  306. EFFECTIVENESS OF A REHABILITATION PROGRAM IN MORBIDLY OBESE SUBJECTS WITH SLEEP DISTURBANCIES
  307. Supported Arm Training in Patients Recently Weaned From Mechanical Ventilation
  308. Early physiotherapy in the respiratory intensive care unit
  309. Length and Clinical Effectiveness of Pulmonary Rehabilitation in Outpatients With Chronic Airway Obstruction
  310. Inpatient pulmonary rehabilitation: does it make sense?
  311. Assessment of Physiologic Variables and Subjective Comfort Under Different Levels of Pressure Support Ventilation
  312. Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation
  313. Long-term mechanical ventilation and nutrition
  314. Occupational Therapy and Pulmonary Rehabilitation of Disabled COPD Patients
  315. Effects of Respiratory Therapist-Directed Protocol on Prescription and Outcomes of Pulmonary Rehabilitation in COPD Inpatients
  316. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
  317. Exhaled nitric oxide and exercise tolerance in severe COPD patients
  318. In-Hospital Short-term Training Program for Patients With Chronic Airway Obstruction
  319. Physiological Response to Pressure Support Ventilation Delivered before and after Extubation in Patients Not Capable of Totally Spontaneous Autonomous Breathing
  320. Erratum
  321. Comparison of Two Methods for Weaning Patients with Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation for More Than 15 Days
  322. Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease
  323. Exhaled nitric oxide in patients with PiZZ Phenotype-related α 1-anti-trypsin deficiency
  324. The Appropriate Setting of Noninvasive Pressure Support Ventilation in Stable COPD Patients
  325. Production of Endogenous Nitric Oxide in Chronic Obstructive Pulmonary Disease and Patients with Cor Pulmonale
  326. Physiologic effects of early administered mask proportional assist ventilation in patients with chronic obstructive pulmonary disease and acute respiratory failure
  327. Preliminary results on nursing workload in a dedicated weaning center
  328. Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies
  329. Exhaled Nitric Oxide and Exercise in Stable COPD Patients
  330. Physiological effects of posture on mask ventilation in awake stable chronic hypercapnic COPD patients
  331. DETECTION OF NITRIC OXIDE IN EXHALED AIR OF DIFFERENT ANIMAL SPECIES USING A CLINICAL CHEMILUMINESCENCE ANALYSER
  332. Differences in spontaneous breathing pattern and mechanics in patients with severe COPD recovering from acute excerbation
  333. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation
  334. Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency
  335. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis
  336. Evaluation in pulmonary rehabilitation
  337. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation
  338. Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases
  339. Transcutaneous Partial Oxygen Tension and Lung Mechanics During Methacholine Inhaled Challenge
  340. Ceftizoxime in Lower Respiratory Tract Infection